Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Seattle WA, Edmonton, Salt Lake City UT, Los Angeles CA,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Seattle WA, Vancouver, Vancouver WA, Eugene OR, Calgary,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

Platelet-rich Fibrin and Grooving for Sagittal Split Osteotomy

for
Inferior Alveolar Nerve Injury, Nerve Injury,
Location: Seattle WA
Sponsor: Jesse Han

Sex: All

Age: 18+

Code: NCT04706182

Recruiting

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

for
Estrogen Receptor-Positive, HER2-Negative,
Location: Seattle WA
Sponsor: EnhancedBio USA Inc.

Sex: All

Age: 18+

Code: NCT04669587

Phase1, Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Spokane WA, Eugene OR, Sacramento CA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

for
Extensive Stage Small Cell Lung Cancer
Location: Seattle WA, Los Angeles CA, Sioux Falls SD, Chicago IL,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06598306

Phase1, Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

for
Colorectal Neoplasms, Gastrointestinal Neoplasms
Location: Seattle WA, Aurora CO, Tucson AZ, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06663319

Phase1, Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Seattle WA, Las Vegas NV, Oklahoma City OK, Tyler TX,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase2, Recruiting

Minimally Invasive Esophagectomy Pain Control Trial

for
Postoperative Pain, Acute, Postoperative Complications
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT05906134

Phase1, Phase2, Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

for
Relapsed/Refractory B-cell Malignancies
Location: Seattle WA, Portland OR, Denver CO, Dallas TX,
Sponsor: Accutar Biotechnology Inc

Sex: All

Age: 18+

Code: NCT05780034

Phase1, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Seattle WA, Portland OR, Louisville KY, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase1, Phase2, Recruiting

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

for
Diffuse Large B Cell Lymphoma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03736616

Phase2, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Seattle WA, Edmonds WA, Issaquah WA, Portland OR,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

for
Psoriatic Arthritis
Location: Seattle WA, Covina CA, Phoenix AZ, Mesa AZ, Tucson AZ,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671496

Phase3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Seattle WA, Portland OR, Eugene OR, Santa Rosa CA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Seattle WA, Edmonds WA, Issaquah WA, Portland OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic ER+ HER2- Breast Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT04606446

Phase2, Recruiting

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

for
Hematological Malignancy, Solid Tumor Malignancy
Location: Seattle WA, Cincinnati OH, Charlotte NC, Baltimore MD
Sponsor: Century Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05768269

Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Seattle WA, Duarte CA, Aurora CO, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase1, Recruiting

A Registry Study of Breast Microseed Treatment

for
Breast Neoplasms
Location: Seattle WA, Pittsburgh PA, Fredericksburg VA
Sponsor: Concure Oncology-Breast Microseed Inc.

Sex: Female

Age: 50+

Code: NCT02701244

Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle